Johannes Grillari’s Post

👀 Check out our new range of 𝘁𝗲𝗹𝗼𝗺𝗲𝗿𝗶𝘇𝗲𝗱 𝗽𝗲𝗿𝗶𝗻𝗮𝘁𝗮𝗹 𝗰𝗲𝗹𝗹𝘀 that can be grown without limitations in vitro, while preserving cell type-specific markers and functions. These cells are derived from different regions of the placenta and offer standardizable models for critical research areas such as placental barrier function and toxicity assays.  Our MSC cells grown under xeno-free conditions with full-documentation and can also be transferred to GMP facilities to produce clinical-grade extracellular vesicles (EVs). Our perinatal cells include: • P-EP/SVTERT344 - 𝗔𝗺𝗻𝗶𝗼𝘁𝗶𝗰 𝗘𝗽𝗶𝘁𝗵𝗲𝗹𝗶𝗮𝗹 𝗖𝗲𝗹𝗹𝘀 https://lnkd.in/dCAVtEvd • P-MSC/TERT308 - 𝗣𝗹𝗮𝗰𝗲𝗻𝘁𝗮𝗹 𝗔𝗺𝗻𝗶𝗼𝗻 𝗠𝗦𝗖𝘀 https://lnkd.in/dERRhnWQ • CP-MSC/TERT308 - 𝗣𝗹𝗮𝗰𝗲𝗻𝘁𝗮𝗹 𝗖𝗵𝗼𝗿𝗶𝗼𝗻𝗶𝗰 𝗣𝗹𝗮𝘁𝗲 𝗠𝗦𝗖𝘀 https://lnkd.in/dtn-v9SQ  • RA-MSC/TERT308 - 𝗥𝗲𝗳𝗹𝗲𝗰𝘁𝗲𝗱 𝗔𝗺𝗻𝗶𝗼𝗻 𝗠𝗦𝗖𝘀 https://lnkd.in/dsMNnVVa By leveraging telomerized cells, Evercyte continues to overcome the limitations of normal primary and tumor cells, delivering long-term growth potential while maintaining essential cell characteristics.   Read the PR ➡️ https://lnkd.in/dC-Ek8Ad #Evercyte #TelomerizedCells #PerinatalCells #MSC #EVs

🎉 Celebrating the Nobel Prize in Physiology or Medicine 2024! 🎉 Congratulations to Victor Ambros and Gary Ruvkun, this year’s Nobel Laureates, for their pioneering discovery of microRNAs—tiny but powerful molecules that regulate gene expression and have reshaped our understanding of biology, aging, cancer, and development. At TAmiRNA GmbH, we’ve been deeply inspired by this breakthrough and have dedicated over 10 years to harnessing the potential of microRNAs. We’ve developed cutting-edge diagnostic tools that leverage microRNAs as biomarkers, with our regulatory approved hepatomiR® device leading the way in improving liver cancer patient care across Europe. Our passion for innovation has resulted in over 100 scientific publications, and we’re proud to contribute to advancing this transformative field. The Nobel Prize serves as a reminder of the impact that these discoveries can have on medical technologies, and we’re committed to pushing the boundaries further—developing novel diagnostic and therapeutic solutions based on this incredible science. 🔬 Let’s continue to drive innovation in healthcare together! #NobelPrize #microRNA #Innovation #TAmiRNA #MedicalTechnology #Biotech #CancerResearch #LiverCancer #Diagnostics

NEW JOB AD OUT FOR A SENIOR SCIENTIST AT a:head bio AG https://lnkd.in/gDcvkbm8

🤩 Abstract submission and early registration for the #ISEV2025 Annual Meeting are now open! 🎼 Submit your abstracts before November 3rd: https://buff.ly/4e8W0Xu Eva Rohde, Eva-Maria Krämer-Albers, An Hendrix, Andreas Möller, Bo Li (李博), Edit Buzás, Johannes Grillari, Lucia Languino, Mario Gimona, Sun Young Lee, Wolfgang Holnthoner

Congratulations to our Nefertiti Chaves-Solano on winning the Best Oral Presentation Award at the #IPLASS and #CTESS Joint International Conference for her talk: “Pro-regenerative miRNAs derived from human amniotic membrane”. As part of our Cell-based Therapies research group, Nefertiti investigates pro-regenerative bioactive factors derived from the human amniotic membrane and evaluates their impact on tissue regeneration signaling pathways. The use of these bioactive factors, instead of cells, might facilitate more specific and effective therapeutic interventions in the future.